Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fortis Life Sciences
Waltham, Massachusetts, United Statesfortislife.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Fortis Life Sciences delivers high-quality reagents, nanomaterials, and custom solutions for biopharma, diagnostics, academic research and applied industries. It has rapidly grown through acquisition of complementary brands since its founding in 2020. The company supports customers with ISO/GMP-certified manufacturing sites across North America.
- Modalities
- NanoparticleProteinGenomics tools/reagentsDiagnostic assay componentsBiologic
- Industry
- Chemicals & Materials
02
Partnerships
No major pharma partnerships disclosed; works with global biopharma/diagnostic customers.
Beyond the preview
Go deeper on Fortis Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fortis Life Sciences.